Todd M. Morgan
University of Michigan
H-index: 64
North America-United States
Top articles of Todd M. Morgan
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
PROSTATE MRI WITHOUT CONTRAST: OPPORTUNITY TO REDUCE FINANCIAL TOXICITY AND IMPROVE ACCESS FOR PATIENTS WITH PROSTATE CANCER | Urologic Oncology: Seminars and Original Investigations | Benjamin Pockros Matthew S Davenport Kristian Stensland Rishi Sekar Todd Morgan | 2024/3/1 |
Impact of Circulating Tumor Cell–Expressed Prostate-Specific Membrane Antigen and Prostate-Specific Antigen Transcripts in Different Stages of Prostate Cancer | Clinical Cancer Research | Hyungseok Cho Seok-Soo Byun Nak-Hoon Son Jae Il Chung Won Ik Seo | 2024/5/1 |
PD29-09 PROSTATE CANCER AND SOLID ORGAN TRANSPLANTATION: PATIENT MANAGEMENT AND OUTCOMES | The Journal of Urology | Alon Lazarovich Tanya W Kristof Aaron Dahmen Shavano Steadman Todd Morgan | 2024/5 |
Disparities in prostate cancer mortality and clinical trial availability across vulnerable populations. | Rishi Sekar Todd Matthew Morgan Lauren P Wallner Kristian Stensland Lindsey A Herrel | 2024/2/1 | |
Safety and clinical validity of tumor genomic testing for guiding active surveillance selection in men with NCCN intermediate-risk prostate cancer. | Lauren Lenz Wyatt Clegg Diana Iliev Howard Korman Todd Matthew Morgan | 2024/2/1 | |
UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSITICATION IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER | Urologic Oncology: Seminars and Original Investigations | Udit Singhal Todd M Morgan Ralph Jiang Matthew Schipper Elizabeth Chase | 2024/3/1 |
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer | JAMA oncology | Jeffrey J Tosoian Yuping Zhang Lanbo Xiao Cassie Xie Nathan L Samora | 2024/4/18 |
PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION? | The Journal of Urology | Madison Krischak Samuel Kaffenberger Jeffrey Montgomery Ganesh Palapattu Tudor Borza | 2024/5 |
National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer | Urology | Kristian D Stensland Megan EV Caram Daniel J Herr Jennifer A Burns Jordan B Sparks | 2024/2/1 |
Real-world effectiveness of PARP inhibitors (PARPi) in metastatic castration-resistant prostate cancer (mCRPC) by genomic homologous recombination repair (HRR) alterations and … | Daniel Triner Ryon Graf Ole Gjoerup Hanna Tukachinsky Jeffrey S Ross | 2024/2/1 | |
ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY | Urologic Oncology: Seminars and Original Investigations | Rishi R Sekar Todd Morgan Lauren Wallner Kristian Stensland Lindsey Herrel | 2024/3/1 |
Abstract LB110: Impact of circulating tumor cell-expressed prostate-specific membrane antigen and prostate-specific antigen transcripts in various stages of prostate cancer | Cancer Research | Hyungseok Cho Seok-Soo Byun Nak-Hoon Son Jae Il Chung Won Ik Seo | 2024/4/5 |
PD19-06 ASSESSING THE CLINICAL UTILITY OF PUBLISHED PROSTATE CANCER POLYGENIC RISK SCORES IN A LARGE BIOBANK DATASET | The Journal of Urology | Helen H Sun Udit Singhal Frederick R Schumacher Erika Trapl Lars G Fritsche | 2024/5 |
Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG … | Edwin Melencio Posadas Hiram Alberto Gay Joseph P Rodgers Todd Matthew Morgan Ying Xiao | 2024/2/1 | |
Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis | Clinical Gastroenterology and Hepatology | Darine Daher Karim Seif El Dahan Alva Cano Michael Gonzales Crystal Ransom | 2024/2/1 |
PD42-03 UNDERSTANDING POPULATION-WIDE GENOMIC RISK DISTRIBUTION AND INTEGRATING CLINICAL-GENOMIC RISK FOR PROGNOSTICATION IN PROSTATE CANCER | The Journal of Urology | Udit Singhal Ralph Jiang Matthew Schipper James Proudfoot Elisabeth Chase | 2024/5 |
A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer | American Journal of Clinical Pathology | Sarah E Bergholtz Sophia R Kurnot Esha Elahi Melissa DeJonckheere Sarah T Hawley | 2024/2/22 |
Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium | Urologic Oncology: Seminars and Original Investigations | Daniel Triner Stephanie Daignault-Newton Udit Singhal Michael Sessine Robert T Dess | 2024/4/2 |
PD57-07 IMPACT OF QUALITY IMPROVEMENT INITIATIVE TIED TO VALUE-BASED REIMBURSEMENT METRIC ON SALVAGE THERAPY UTILIZATION AFTER RADICAL PROSTATECTOMY | The Journal of Urology | Arsyad Santosa Apoorv Dhir Kevin Ginsburg Tudor Borza Anna Johnson | 2024/5 |
Federal Oversight of Laboratory-Developed Tests. Reply. | The New England Journal of Medicine | Udit Singhal Aaron S Kesselheim Todd M Morgan | 2024/2/1 |
Co-Authors
